CLPBF(CLPBF)
CLPBF
No analyst ratings available
No analyst price targets available for CLPBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $29.38B | $31.36B | $33.38B | $35.94B | $38.43B |
| Low | $29.15B | $30.89B | $33.00B | $35.53B | $37.99B |
| High | $29.58B | $31.91B | $33.80B | $36.39B | $38.91B |
| EBITDA Avg | $9.47B | $10.11B | $10.76B | $11.58B | $12.39B |
| Low | $9.40B | $9.96B | $10.63B | $11.45B | $12.24B |
| High | $9.53B | $10.29B | $10.89B | $11.73B | $12.54B |
| EBIT Avg | $8.16B | $8.72B | $9.28B | $9.99B | $10.68B |
| Low | $8.10B | $8.59B | $9.17B | $9.87B | $10.56B |
| High | $8.22B | $8.87B | $9.39B | $10.11B | $10.81B |
| Net Income Avg | $5.79B | $6.03B | $6.51B | $7.30B | $7.76B |
| Low | $5.29B | $5.94B | $6.41B | $7.19B | $7.65B |
| High | $6.86B | $6.12B | $6.61B | $7.42B | $7.89B |
| EPS Avg | $25.70 | $26.73 | $28.87 | $32.39 | $34.44 |
| Low | $23.48 | $26.34 | $28.44 | $31.91 | $33.93 |
| High | $30.44 | $27.17 | $29.34 | $32.92 | $35.00 |
| Analysts (Rev / EPS) | 20 / 11 | 20 / 7 | 9 / 9 | 10 / 9 | 10 / 4 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $7.49B | $7.56B |
| Low | $7.36B | $7.42B |
| High | $7.59B | $7.66B |
| EBITDA Avg | $2.41B | $2.44B |
| Low | $2.37B | $2.39B |
| High | $2.45B | $2.47B |
| EBIT Avg | $2.08B | $2.10B |
| Low | $2.04B | $2.06B |
| High | $2.11B | $2.13B |
| Net Income Avg | $1.27B | $1.58B |
| Low | $1.24B | $1.55B |
| High | $1.29B | $1.61B |
| EPS Avg | $5.61 | $7.03 |
| Low | $5.49 | $6.87 |
| High | $5.71 | $7.15 |
| Analysts (Rev / EPS) | 8 / 1 | 5 / 1 |